Even chemistry is more fun in Europe...
FDA clears IND for clinical trial testing switchable CAR-T therapy in
patients with autoimmune diseases, without chemotherapy
-
FDA has cleared an investigational new drug (IND) application to study
switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 +
SWI019) in p...
3 days ago
Posts
No comments:
Post a Comment